CIK 0001736730 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Camp4 Therapeutics Corp
Sign in to watch- Ticker
- CAMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-651-8867
- Business address
- 100 TALCOTT AVENUE, SUITE 201, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $39,600
- in 1 filing
- Open-market sales, last 90 days
- $2,504,037
- in 4 filings
Net −$2,464,437. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-01 | Gold Kelly Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +215,000 | 215,000 | ||
| 2026-04-01 | Mandel-Brehm Josh Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +580,000 | 580,000 | ||
| 2026-04-01 | Maricich Yuri Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +215,000 | 215,000 | ||
| 2026-04-01 | MacLean Michael F Director | Grant or award · Stock Option (Right to Buy) | +56,000 | 56,000 | ||
| 2025-12-11 | Tardiff Daniel Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +145,500 | 145,500 | ||
| 2025-12-11 | Gold Kelly Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2025-12-11 | Mandel-Brehm Josh Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +425,000 | 425,000 | ||
| 2025-12-11 | Maricich Yuri Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +190,000 | 190,000 | ||
| 2025-09-11 | Schwab Andrew J. Director | Grant or award | +2,941,176 | $1.53 | $4.5M | 2,941,176 |
| 2025-09-11 | 5AM Partners VI, LLC 10% owner | Purchase | +2,941,176 | $1.53 | $4.5M | 2,941,176 |
| 2025-09-11 | Gold Kelly Chief Financial Officer | Purchase | +6,060 | $1.65 | $10K | 67,877 |
| 2025-09-11 | Mandel-Brehm Josh Chief Executive Officer | Purchase | +6,060 | $1.65 | $10K | 278,417 |
| 2025-09-11 | Maricich Yuri Chief Medical Officer | Purchase | +6,060 | $1.65 | $10K | 6,060 |
| 2025-09-11 | Young Richard A Director | Purchase | +15,151 | $1.65 | $25K | 170,010 |
| 2025-09-11 | Polaris Management Co. VII, L.L.C. 10% owner | Purchase | +1,221,721 | $1.53 | $1.9M | 2,825,500 |
| 2025-09-11 | Polaris Management Co. VII, L.L.C. 10% owner | Purchase | +85,468 | $1.53 | $131K | 197,661 |
| 2025-09-11 | Nashat Amir Director | Purchase | +1,221,721 | $1.53 | $1.9M | 2,825,500 |
| 2025-09-11 | Nashat Amir Director | Purchase | +85,468 | $1.53 | $131K | 197,661 |
| 2025-06-25 | Boylan James P Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2025-06-25 | Young Richard A Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 |
Page 2 of 6 · 111 trades